- Presentations
- 4
- Markets
- 1
Epclusa is a brand of Sofosbuvir and Velpatasvir marketed by Gilead Sciences, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sofosbuvir and Velpatasvir
- Brand owner
- Gilead Sciences
- Registered in
- United States
- Strengths and forms
- 150 mg/37.5 mg oral pellets, 200 mg/50 mg oral pellets, 200 mg/50 mg tablet, 400 mg/100 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Epclusa 150 mg/37.5 mg oral pelletsOral | Gilead Sciences | US FDA | Available on request |
| Epclusa 200 mg/50 mg oral pelletsOral | Gilead Sciences | US FDA | Available on request |
| Epclusa 200 mg/50 mg tabletOral | Gilead Sciences | US FDA | Available on request |
| Epclusa 400 mg/100 mg tabletOral | Gilead Sciences | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Epclusa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.